Plain-English translation of NCT06749847 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two new approaches to cervical cancer screening in France to see if they help more women participate. Instead of requiring all women to visit a healthcare provider, this study compares sending screening kits directly to homes, offering a choice between home testing or clinic visits, and the standard approach. The researchers want to understand whether these easier options increase screening participation and are acceptable to women.
In France, cervical cancer screening rates are lower than recommended, meaning many women who could catch early signs of cancer are not being screened. This trial explores whether making screening more convenient—by offering home-based testing options—can help more women participate and ultimately prevent more cases of cervical cancer.
You likely qualify if…
You likely don't qualify if…
Depending on which group you're randomly assigned to, you may receive a screening kit in the mail that you use at home, be given the choice to order a kit or visit a clinic, or follow the standard screening procedure. If you test positive on the screening, you'll receive support or reminders to complete follow-up testing. The study will track whether you participate and how easy or acceptable you find the screening method.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
France